What is Lifesci Capital’s Forecast for ELVN FY2025 Earnings?
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) – Equities research analysts at Lifesci Capital upped their FY2025 earnings estimates for Enliven Therapeutics in a report issued on Thursday, May 29th. Lifesci Capital analyst S. Slutsky now expects that the company will post earnings per share of ($2.26) for the year, up from their previous estimate […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) – Equities research analysts at Lifesci Capital upped their FY2025 earnings estimates for Enliven Therapeutics in a report issued on Thursday, May 29th. Lifesci Capital analyst S. Slutsky now expects that the company will post earnings per share of ($2.26) for the year, up from their previous estimate […]
